Salus Labs, Inc. — Form D
Salus Labs, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-13. The offering totals $35.0M, of which $35.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-05-13
- Form: D
- Accession: 0001776609-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $35.0M
- Investors: 6
- Date of first sale: 2019-03-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339440
Issuer
- Name: Salus Labs, Inc.
- CIK: 0001776609
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 301 HOWARD STREET, SUITE 550, SAN FRANCISCO, CA, 94105
- Phone: (415) 209-5640
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ammon Bartram | Director | San Francisco, CA |
| Guillaume Luccisano | Director | Cambridge, MA |
| ALI ROWGHANI | Director | SAN FRANCISCO, CA |
| Harjeet Taggar | Director | San Francisco, CA |
| Garry Tan | Director | San Francisco, CA |
| Harjeet Taggar | Executive Officer | San Francisco, CA |
More